Cargando…

TTN mutations predict a poor prognosis in patients with thyroid cancer

Objective: We aimed to investigate the relationship between titin (TTN) gene mutations and thyroid cancer (THCA) and to explore the feasibility of the TTN gene as a potential prognostic indicator of THCA. Methods: From TCGA-THCA cohort, we performed a series of analyses to evaluate the prognostic va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiudan, Chen, Jianrong, Wang, Jiao, Xu, Jixiong, Liu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310696/ https://www.ncbi.nlm.nih.gov/pubmed/35766333 http://dx.doi.org/10.1042/BSR20221168

Ejemplares similares

High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration
por: Wang, Hai yue, et al.
Publicado: (2023)

Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma
por: Liu, Xianhui, et al.
Publicado: (2020)

Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
por: Li, Jiangfen, et al.
Publicado: (2019)

Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: a meta-analysis
por: Wang, Yanyan, et al.
Publicado: (2020)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

Overexpression of SKA3 correlates with poor prognosis in female early breast cancer
por: Zhong, Yue, et al.
Publicado: (2021)

High PHD Finger Protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study
por: Li, Pengfei, et al.
Publicado: (2021)

Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
por: Li, Ruowen, et al.
Publicado: (2023)

Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer
por: Yu, Zeying, et al.
Publicado: (2022)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)

Corrigendum: Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer
por: Yu, Zeying, et al.
Publicado: (2022)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Mingzhe, et al.
Publicado: (2020)

A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA
por: Wang, Ke, et al.
Publicado: (2021)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
por: Liao, Qingyun, et al.
Publicado: (2023)

Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer
por: Wang, Hongbo, et al.
Publicado: (2023)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

CRYAB predicts clinical prognosis and is associated with immunocyte infiltration in colorectal cancer
por: Deng, Junsheng, et al.
Publicado: (2021)

Establishment of a 12-gene expression signature to predict colon cancer prognosis
por: Sun, Dalong, et al.
Publicado: (2018)

Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis
por: Xu, Dafeng, et al.
Publicado: (2020)

ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022)

Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis
por: Wei, Chao, et al.
Publicado: (2019)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis
por: Han, Xiudan, et al.
Publicado: (2022)

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
por: Li, Xin, et al.
Publicado: (2020)

A cholesterogenic gene signature for predicting the prognosis of young breast cancer patients
por: Li, Xiaoping, et al.
Publicado: (2022)

The m(6)A-related gene signature for predicting the prognosis of breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment
por: Tian, Yixin, et al.
Publicado: (2020)

A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
por: Lai, Cong, et al.
Publicado: (2021)

Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis
por: Bu, Luping, et al.
Publicado: (2021)

ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway
por: Yu, Ruoxi, et al.
Publicado: (2019)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes
por: Han, Ke, et al.
Publicado: (2021)

TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
por: Li, Jia, et al.
Publicado: (2021)

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients
por: Liu, Feng, et al.
Publicado: (2022)

High mutations in fatty acid metabolism contribute to a better prognosis of small‐cell lung cancer patients treated with chemotherapy
por: Lyu, Qiong, et al.
Publicado: (2021)

Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma
por: Hao, Haiyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ahnka0quagbbqhjq1ji886hin8